Spyros Kalams Archives
Clinical Trials Unit lands major grant renewal
Feb. 11, 2021—Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19.
HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine
Dec. 21, 2020—Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.
Major international study testing therapy to prevent spread of HIV
Oct. 5, 2017—Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).
Flu vaccine response in older adults
Jan. 25, 2017—High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.
First subject enrolled in international HIV prevention study
Apr. 14, 2016—This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.
AIDS Clinical Trials Unit lands renewal of NIH funding
Jan. 30, 2014—Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).
HIV’s impact on B cells
Jan. 15, 2014—Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
